ZIRABEV

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: d3f0f0802951014c
Drug Approval Canada Name: ZIRABEV
Product Name: ZIRABEV
Status: Marketed
Status Date: 2019-09-25
Original Market Date: 2019-09-25
Din: 02489430
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FG01 BEVACIZUMAB
Atc Name: l 01 fg 01
Aig Number: 0151381001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

BEVACIZUMAB

100 MG / 4 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d3f0f0802951014c

Type

Standard